BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

Clinical trial NCT05370430 · RECRUITING

Trial details

NCT number: NCT05370430
Sponsor: PeproMene Bio, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Start date: 2022-06-13
Primary completion: 2027-07-13
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.